CLINICAL_TRIALS trial_result · 2011-10-03

Clinical Trial Update: A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis [Phase 2]

Phase 2 proof-of-concept and dose-ranging trial in rheumatoid arthritis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2011-10-03